Send to friend Linked
Avigen
|
| Website | http://www.avigen.com/ |
|---|---|
| Location | San Francisco |
| Industry | Healthcare & Pharmaceuticals |
| Revenue | unknown |
| Investment | unknown |
| Growth | unknown |
| Employees | unknown |
"Avigen is committed to providing physicians and their patients with innovative therapeutics for the treatment of serious, chronic neurological conditions-what makes us unique is how we plan to get there. We are committed to exploring novel mechanisms that shorten the path to results. Not just different-positively different.
It begins with investigating and understanding the problem as never before. Once we know why we can understand how. Our strategy is to build a robust pipeline through a combination of internal research, acquisitions and in-licensing, with the goal of becoming a fully integrated pharmaceutical company."
(Source: Avigen)
-
News: Biotech Companies Cut Back, Avoid Bankruptcy, Chronicle Says
-
News: Drastic cuts among some biotech companies
-
News: Tengion Announces Second Closing of Series C Financing
-
News: Biotechs claw for their lifeblood - financing
-
News: Addiction Therapeutics Reviewed by NeuroInvestment
-
News: Zacks #1 Rank Additions for Wednesday
-
News: Closures & Layoffs (Nov. 2-8): Another Week, Another Round of Fortune 500 Layoffs
-
News: DGAP-News: Sanochemia Pharmazeutika AG: No further cooperation with Avigen
-
News: test2
-
News: Avigen to cut staff by 70 per cent
